Digital transformation is one of the most significant Europe CRO Market trends reshaping how clinical trials are conducted. The adoption of decentralized clinical trial (DCT) models, which use virtual visits, remote sampling, and mobile health technologies, is rapidly increasing. These models significantly reduce the burden on patients by eliminating the need for frequent site visits.

Real-world data (RWD) and real-world evidence (RWE) are also becoming central to trial design and post-approval studies. European CROs are investing in data platforms and partnerships to capture RWD from electronic health records, wearable devices, and patient registries. This shift towards evidence-based trial designs not only enhances regulatory robustness but also speeds up development timelines. For trend-based insights, check: Europe CRO Market trends – https://www.marketresearchfuture.com/reports/europe-cro-market-12633

FAQ

Q: Why are decentralized trials growing in Europe?
Because they improve patient convenience and reduce trial costs.
Q: What is the role of real-world evidence?
It supports more robust trial models and helps in regulatory decision-making.